Track topics on Twitter Track topics that are important to you
The leading Frenchindependent pharmaceutical company
for diseases of major importance
17 500 employees worldwide,
including 2500 in Research and Development
Established in 140 countries
Servier turnover: 2.8 billion
22 rue Garnier
Phone: 33 1 55 72 60 00
Servier, a French pharmaceutical firm, has sought to lower the fine it received from the European Commission for breaching antitrust regulations back in 2014. The company, alongside five producers of ...
As part of its collaboration with Belgium-based biotech Galapagos, Servier has exercised its option to…
French company Servier is to stop producing and selling its osteoporosis treatment Protelos (strontium…
Independent drugmaker Servier has signed a deal with fellow French firm ILTOO Pharma in a partnership…
Servier and Transgene have entered into a three-year research partnership that will analyze how Transgene's viral vectorizati -More-
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Servier: Head of Department: Cellular Sciences – Suresnes, Paris Area,...
Servier has gained an option to develop and commercialize Iltoo Pharma’s autoimmune disease candidate ILT-100 (low-dose interleukin-2) next year following results of an ongoing Phase II trial, the c...
Privately-held French pharma firm Servier and US biotech miRagen Therapeutics have extended their research…
To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. T...
The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...
The main purpose of this study is to assess comparative bioavailability of two test formulations of Gliclazide 120 mg Modified Release tablets (120 mg gliclazide per modified release table...
The purpose of the study is to compare the bioavailability of a generic product of gliclazide (Product Name: BF-Gliclazide Tablet 80mg, Manufactured by Bright Future Pharmaceuticals Factor...
Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fed, Healthy, Adult Subjects
- Objective: - A Randomized, Two-Way Crossover, Single-Dose, Open-Label Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Co...
The leading Frenchindependent pharmaceutical company Reference productsfor diseases of major importance 17 500 employees worldwide,including 2500 in Research and Development Established...
PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...
Since 1989, DW Coordinating Center and its partner, Clinical Pharmacological Research (CPR), St. Petersburg, Russia, have conducted major multinational clinical trials in the former Soviet Union for H...
SQI Diagnostics is a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics. The Companyâs proprieta...
We have published hundreds of incorporated company of SERVIER news stories on BioPortfolio along with dozens of incorporated company of SERVIER Clinical Trials and PubMed Articles about incorporated company of SERVIER for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of incorporated company of SERVIER Companies in our database. You can also find out about relevant incorporated company of SERVIER Drugs and Medications on this site too.